Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000220556 | SCV000279811 | uncertain significance | not provided | 2016-01-25 | criteria provided, single submitter | clinical testing | The M164V variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. This variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI ExomeSequencing Project, indicating it is not a common benign variant in these populations. This substitution occurs at aposition that is conserved in mammals. However, Valine is the wild-type amino acid at this position in as least twospecies. In addition, the M164V variant is a conservative amino acid substitution, which is not likely to impactsecondary protein structure as these residues share similar properties. In silico analysis is inconsistent in itspredictions as to whether or not the variant is damaging to the protein structure/function. Furthermore, no pathogenicmissense variants in nearby residues have been reported in the Human Gene Mutation Database (Stenson et al., 2014). Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or benign. |